Teva's stunning list of cuts targets 14K jobs, $3B in costs and plants around the globe | Fierce Pharma
Patients Eagerly Awaited a Generic Drug. Then They Saw the Price. - The New York Times
Teva Announces Nationwide Opioids Settlement to Move Forward After Receiving Broad Support from States | Business Wire
Teva Pharmaceutical reports Q1 2018 | AlphaStreet
Transitioning Teva revamps branding to emphasize brand-generic unity | Fierce Pharma
$40 million incentive lures global pharmaceutical giant to Parsippany
Lured by $40 million tax break, Teva moving U.S. headquarters from Pa. to North Jersey - WHYY
Teva | Partnership | Direct Relief
13 Teva : Top 25 Pharma & BioPharma in 2018 | Contract Pharma
Teva down as it reports lower sales and profit for 2018
Teva Plunges as U.S. Sales Drop Amid Generic Price Erosion - Bloomberg
Pharma giant Teva promises to create over 800 jobs in N.J. Are they worth $40M? - nj.com
HOPA News Volume 15 Issue 4b : HOPA News Volume 15 Issue 4
Teva introduces QVAR RediHaler inhalation aerosol in US - Pharmaceutical Technology
Teva Reports Massive $11.6 Billion Loss, Predicts Weak 2018 - Business - Haaretz.com
Teva Pharmaceutical Shares Plunge After Quarterly Loss and 2018 Outlook Warning - WSJ
Award of Merit Manufacturing: TEVA Biologics Manufacturing Facility | 2018-10-16 | Engineering News-Record
Here's Why Teva Pharma Stock Is Soaring Today
Teva Pharmaceuticals Soars After Buffett's Berkshire Hathaway Discloses Stake
Teva Announces New Brand Positioning and Visual Identity in North America
Teva recalls US-made drugs following contamination fears - The Boston Globe
Teva selects North Jersey site for its new North American headquarters. - Philadelphia Business Journal
Teva Becomes First Pharmaceutical Company to Execute Sustainability-Linked Bond Tied to Both Climate and Access to Medicine Targets | News Direct
Jury finds Teva Pharmaceuticals fueled opioid epidemic in New York State
Battered by a Tough Generics Market, Teva Pharma Emphasizes Biologics | BioSpace
FDA approves a generic version of Teva Pharmaceutical's best-selling drug; company shares tumble
